Search research articles
Contact Us
Filters
Showing results (391-400 of 1,126) with videos related to
Page
of 113
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
Jochen Walz, Andrea Gallina, Fred Saad, et al.
Journal of Surgical Oncology
|
August 20, 2020
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis
Angela Pecoraro, Sophie Knipper, Carlotta Palumbo, et al.
Urologic Oncology
|
July 31, 2021
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma
Claudia Collà Ruvolo, Mike Wenzel, Luigi Nocera, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
September 14, 2013
CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update
Fred Saad, Sebastien Hotte, Charles Catton, et al.
The Journal of Urology
|
February 9, 2023
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
European Urology Focus
|
December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data
Benedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
Future Oncology (London, England)
|
August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2019
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies
Elio Mazzone, Sophie Knipper, Francesco A Mistretta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study
Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, et al.
Page
of 113
Search research articles
Search
Showing results (391-400 of 1,126) with videos related to
Sort By:
Page
of 113
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2007
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
Jochen Walz, Andrea Gallina, Fred Saad, et al.
Journal of Surgical Oncology
|
August 20, 2020
Assessment of other-cause mortality in localized renal cell carcinoma patients within 15 years: A population-based analysis
Angela Pecoraro, Sophie Knipper, Carlotta Palumbo, et al.
Urologic Oncology
|
July 31, 2021
The effect of race on stage at presentation and survival in upper tract urothelial carcinoma
Claudia Collà Ruvolo, Mike Wenzel, Luigi Nocera, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
September 14, 2013
CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update
Fred Saad, Sebastien Hotte, Charles Catton, et al.
The Journal of Urology
|
February 9, 2023
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical Trial
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive Agents
Allan Lipton, Matthew R Smith, Karim Fizazi, et al.
European Urology Focus
|
December 6, 2024
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data
Benedikt Hoeh, Mike Wenzel, Zhe Tian, et al.
Future Oncology (London, England)
|
August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?
Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 7, 2019
Trends and Social Barriers for Inpatient Palliative Care in Patients With Metastatic Bladder Cancer Receiving Critical Care Therapies
Elio Mazzone, Sophie Knipper, Francesco A Mistretta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
September 4, 2021
Stage and cancer-specific mortality differ within specific Asian ethnic groups for upper tract urothelial carcinoma: North American population-based study
Claudia Collà Ruvolo, Christoph Würnschimmel, Luigi Nocera, et al.
Page
of 113